Statins lower recurrence and death risk in hormone receptor-positive breast cancer

For women living with hormone receptor-positive breast cancer, every tool that lowers risk matters. A new analysis looked at how common cholesterol drugs called statins affect these patients. The researchers combined data from many studies to get a clear picture of what happens when people take these medications. They found that statin use was linked to a 23 percent lower risk of the cancer coming back. This group also saw a significant drop in the risk of dying from the disease. The study looked at nearly 270,000 people to reach these conclusions. This large number of participants gives the results strong weight. The findings suggest that taking a statin could be an extra layer of protection for these patients. The data shows a clear benefit for both stopping the cancer from returning and keeping patients alive longer. While more research is always good, this evidence is solid enough to discuss with your doctor. It is important to remember that this is about general trends in large groups. Your own health history is unique. Always talk to your medical team before starting or stopping any medicine. They can help you decide if a statin is right for your specific situation.